For the year ending 2025-12-31, SRTS had $27K increase in cash & cash equivalents over the period. $332K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) income | -7,719 |
| Credit loss expense | 44 |
| Depreciation | 386 |
| Amortization of right-of-use asset | 240 |
| Provision for product warranties | -503 |
| Stock-based compensation | 295 |
| Deferred income taxes | -1,882 |
| Accounts receivable | -13,646 |
| Inventories | 4,635 |
| Prepaid inventory | -1,825 |
| Other current assets | 176 |
| Other noncurrent assets | -12 |
| Accounts payable and accrued expenses | -1,468 |
| Operating lease liability | -242 |
| Deferred revenue | 256 |
| Product warranties | 557 |
| Net cash provided by (used in) operating activities | 528 |
| Acquisition of property and equipment | 196 |
| Net cash used in investing activities | -196 |
| Repurchase of common stock | 300 |
| Withholding taxes on stock-based compensation | 5 |
| Net cash (used in) provided by financing activities | -305 |
| Net increase (decrease) in cash and cash equivalents | 27 |
| Cash and cash equivalents beginning of period | 22,056 |
| Cash and cash equivalents end of period | 22,083 |
Sensus Healthcare, Inc. (SRTS)
Sensus Healthcare, Inc. (SRTS)